AIMC Topic: Drug Discovery

Clear Filters Showing 271 to 280 of 1502 articles

A Computational Framework for Predicting Novel Drug Indications Using Graph Convolutional Network With Contrastive Learning.

IEEE journal of biomedical and health informatics
Inferring potential drug indications plays a vital role in the drug discovery process. It can be time-consuming and costly to discover novel drug indications through biological experiments. Recently, graph learning-based methods have gained popularit...

Protein ligand binding site prediction using graph transformer neural network.

PloS one
Ligand binding site prediction is a crucial initial step in structure-based drug discovery. Although several methods have been proposed previously, including those using geometry based and machine learning techniques, their accuracy is considered to ...

Combining machine learning, molecular dynamics, and free energy analysis for (5HT)-2A receptor modulator classification.

Journal of molecular graphics & modelling
The 5-Hydroxytryptamine (5HT)-2A receptor, a key target in psychoactive drug development, presents significant challenges in the design of selective compounds. Here, we describe the construction, evaluation and validation of two machine learning (ML)...

Generative artificial intelligence for small molecule drug design.

Current opinion in biotechnology
In recent years, the rapid advancement of generative artificial intelligence (GenAI) has revolutionized the landscape of drug design, offering innovative solutions to potentially expedite the discovery of novel therapeutics. GenAI encompasses algorit...

Meta Learning With Graph Attention Networks for Low-Data Drug Discovery.

IEEE transactions on neural networks and learning systems
Finding candidate molecules with favorable pharmacological activity, low toxicity, and proper pharmacokinetic properties is an important task in drug discovery. Deep neural networks have made impressive progress in accelerating and improving drug dis...

Navigating the frontier of drug-like chemical space with cutting-edge generative AI models.

Drug discovery today
Deep generative models (GMs) have transformed the exploration of drug-like chemical space (CS) by generating novel molecules through complex, nontransparent processes, bypassing direct structural similarity. This review examines five key architecture...

Progress in the application of artificial intelligence in molecular generation models based on protein structure.

European journal of medicinal chemistry
The molecular generation models based on protein structures represent a cutting-edge research direction in artificial intelligence-assisted drug discovery. This article aims to comprehensively summarize the research methods and developments by analyz...

A Hybrid GNN Approach for Improved Molecular Property Prediction.

Journal of computational biology : a journal of computational molecular cell biology
The development of new drugs is a vital effort that has the potential to improve human health, well-being and life expectancy. Molecular property prediction is a crucial step in drug discovery, as it helps to identify potential therapeutic compounds....

A New Fingerprint and Graph Hybrid Neural Network for Predicting Molecular Properties.

Journal of chemical information and modeling
Machine learning plays a role in accelerating drug discovery, and the design of effective machine learning models is crucial for accurately predicting molecular properties. Characterizing molecules typically involves the use of molecular fingerprints...

From mundane to surprising nonadditivity: drivers and impact on ML models.

Journal of computer-aided molecular design
Nonadditivity (NA) in Structure-Activity and Structure-Property Relationship (SAR) data is a rare but very information rich phenomenon. It can indicate conformational flexibility, structural rearrangements, and errors in assay results and structural ...